|
CURRENT ISSUE
|
With all the latest laboratory science news, stories and unique features to your desktop, tablet or smartphone, Tomorrow's Laboratories is your digital Laboratory Science magazine: a portal for all your lab news. Ovarian cancer project shows promisePublished on 16/11/2020
Porvair Sciences is reporting that it has agreed with its collaborative partners to make additional investment in the CEAT project, which aims to dramatically improve the diagnosis and treatment of ovarian cancer.
Forxiga greenlit for heart failure treatmentPublished on 13/11/2020
AstraZeneca has announced that the European Commission has approved a change to the terms of the marketing authorisation for Forxiga (dapagliflozin).
Partnership creates microfluidic kitsPublished on 12/11/2020
Dolomite Microfluidics and MilliporeSigma have partnered to create a range of off-the-shelf NanoFabTx microfluidic device kits for producing PLGA nano- and microparticles for drug development and controlled drug release applications.
Invasive aspergillosis screening for COVID-19Published on 11/11/2020
IMMY sõna Aspergillus Galactomannan Lateral Flow Assay has been recommended by the European Confederation of Medical Microbiology as a screening device in ventilated patients.
New appointments at OxeltisPublished on 10/11/2020
Oxeltis has announced it has promoted Dr Stéphane Salamone to Director of Chemistry, and appointed Dr Olivier Lavergne as Consultant in Medical Chemistry.
Recombinant monoclonal antibody developmentPublished on 9/11/2020
AMSBIO has announced a new rabbit and mouse recombinant monoclonal antibody development service, based upon a revolutionary technology platform.
|
|
